Merck & Co Inc
Latest Shanghai quarantines add more pressure to global supply chain
Staff members of China Post unload parcels of daily necessities for residents quarantined at home from a minivan on May 14, 2022 in Shanghai, China. Tian Yuhao | China News Service | Getty Images The mass quarantine measures imposed this past weekend in Shanghai, including highway closures, severely affected trucks carrying exports bound for the […]
Read MoreSigns point to biotech M&A heating up, Wells Fargo says. Here’s where to look
The pace of biotech deals is likely to pick up, but investors should think about smaller targets, said Wells Fargo analyst Mohit Bansal. Bansal called out both enticing valuations for small- and mid-cap biotech companies, which are now trading at an enterprise value of about one times cash, on average, and a tough regulatory environment […]
Read MoreWhen the market was tanking, these stocks were hitting all-time highs and could go even higher
While market losses were racking up, this group of stocks was breaking out to all-time highs and looks set for even more gains. The group is Big Pharma. It’s been long viewed as stodgy by investors looking for quicker price gains. Recently, however, as other stocks slid, these companies have become more attractive because of […]
Read MoreMerck sold $3.2 billion of its Covid oral antiviral treatment, driving first-quarter revenue growth
Medicine pill is seen with Merck logo and words ‘Molnupiravir’ and ‘COVID-19’ displayed on a screen in the background in this illustration photo taken in Poland on November 5, 2021. Jakub Porzycki | NurPhoto | Getty Images Merck sold $3.2 billion of its oral antiviral treatment for Covid in the first quarter, fueling the company’s […]
Read MoreMorgan Stanley thinks the S&P 500 is headed for a bear market and offers few places to hide
The S&P 500 looks ready to slide by 20%, according to Morgan Stanley Source
Read MoreMerck’s Keytruda reduced risk of disease recurrence or death in early lung cancer patients by 24%
Stefanie Joho, 27, stands for a portrait at the home of a friend in Penn Valley, PA on Tuesday, May 9, 2017. Joho, who was diagnosed with colon cancer at 22 years old, has been in remission since February 2016, thanks to an immunotherapy drug targeted at specific mutations that prevents repair of DNA-replication mistakes. […]
Read More